Efficacy and safety of ATX-101 as a treatment for submental fullness: A retrospective analysis of two aesthetic practices.

Misha ZarbafianMahsa KaravanRyan GreeneSabrina Guillen Fabi

Published in: Journal of cosmetic dermatology (2019)

Patients achieved progressive improvement in SMF after the 1st and 2nd treatments, as judged by patients themselves, investigators, and blinded evaluators. These results of SMF correction suggest that significant benefit can be obtained with proper dosing at the initial visit. These data support the efficacy and safety profile of ATX-101 use for SMF correction.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
healthcare
peritoneal dialysis
primary care
multiple sclerosis
machine learning
electronic health record
patient reported outcomes
placebo controlled
breast reconstruction